Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024

BUY
$6.53 - $8.23 $103,650 - $130,634
15,873 New
15,873 $127,000
Q1 2023

May 01, 2023

BUY
$6.28 - $9.85 $242,144 - $379,796
38,558 New
38,558 $312,000
Q1 2022

May 17, 2022

SELL
$21.6 - $27.79 $805,982 - $1.04 Million
-37,314 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$23.0 - $29.01 $858,222 - $1.08 Million
37,314 New
37,314 $1.03 Million
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $486,627 - $584,186
-19,434 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$27.43 - $32.7 $198,785 - $236,976
7,247 Added 59.47%
19,434 $570,000
Q1 2021

May 19, 2021

BUY
$21.37 - $34.38 $260,436 - $418,989
12,187 New
12,187 $387,000
Q4 2020

Feb 24, 2021

SELL
$15.31 - $21.12 $269,578 - $371,880
-17,608 Closed
0 $0
Q3 2020

Dec 11, 2020

BUY
$14.88 - $20.13 $262,007 - $354,449
17,608 New
17,608 $274,000
Q4 2019

Feb 04, 2020

SELL
$18.89 - $31.89 $747,193 - $1.26 Million
-39,555 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$20.88 - $25.66 $825,908 - $1.01 Million
39,555 New
39,555 $864,000
Q2 2019

Aug 13, 2019

SELL
$20.52 - $26.45 $672,707 - $867,110
-32,783 Closed
0 $0
Q1 2019

Apr 12, 2019

SELL
$20.23 - $26.29 $331,023 - $430,183
-16,363 Reduced 33.29%
32,783 $810,000
Q4 2018

Jan 16, 2019

BUY
$17.64 - $28.32 $699,655 - $1.12 Million
39,663 Added 418.25%
49,146 $908,000
Q3 2018

Nov 13, 2018

SELL
$20.64 - $25.67 $195,729 - $243,428
-9,483 Reduced 50.0%
9,483 $243,000
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $391,458 - $486,857
18,966 New
18,966 $558,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.7B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.